Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

ClearPoint Neuro, Inc. (CLPT) had Revenue of $31.39M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$31.39M
Net Income	$-18.91M
Cost of Goods Sold	$12.27M
Gross Profit	$19.12M
Operating Expenses	$51.14M
Operating Income	$-19.75M
Non-Operating Income/Expense	$0.83M
Pre-Tax Income	$-18.91M
Normalized Pre-Tax Income	$-18.91M
Income after Taxes	$-18.91M
Income from Continuous Operations	$-18.91M
Consolidated Net Income/Loss	$-18.91M
Normalized Income after Taxes	$-18.91M
EBIT	$-19.75M
EBITDA	$-17.79M
Weighted-Average Shares Outstanding (Basic)	27.03M
Weighted-Average Shares Outstanding (Diluted)	27.03M
Earnings per Share (EPS) (Basic)	$-0.70
Earnings per Share (EPS) (Diluted)	$-0.70
Balance Sheet Financials
Current Assets	$33.36M
Property, Plant, and Equipment	$2.00M
Long-Term Assets	$5.83M
Total Assets	$39.19M
Current Liabilities	$10.35M
Long-Term Debt	--
Long-Term Liabilities	$3.45M
Total Liabilities	$13.80M
Common Equity	$25.39M
Tangible Shareholders Equity	$25.29M
Shareholders Equity	$25.39M
Common Shares Outstanding	27.62M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-8.95M
Cash Flow from Investing Activities	$-0.28M
Cash Flow from Financial Activities	$6.19M
Beginning Cash	$23.14M
End Cash	$20.10M
Increase/Decrease in Cash	$-3.04M
Stock-Based Compensation	$6.91M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.22
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	--
Gross Margin	60.92%
Operating Margin	-62.91%
EBIT Margin	-62.91%
EBITDA Margin	-56.68%
Pre-Tax Profit Margin	-60.25%
Profit Margin	-60.25%
Free Cash Flow	$-9.22M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.80
Inventory Turnover	1.79
Receiveable Turnover	6.66
Days Sales in Receivables	54.80
Return on Equity	-74.50%
Return on Tangible Equity	-74.80%
Return on Assets	-48.26%
Return on Investments	-74.50%
Book Value Per Share	$0.92
Free Cash Flow per Share	$-0.34
Operating Cash Flow per Share	$-0.33

Data from Zacks Investment Research, Inc.